Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani and the UNICEF Launched the National Breastfeeding Campaign

The Ministry of Public Health launched the National Breastfeeding Campaign in collaboration with the UNICEF and the International Orthodox Christian Charities during a special event held at Linda Sursock Villa, Achrafieh under the title: “Breastfeeding is important; the mission of all of us! It is our duty to support you and your right to ask support”.

The event started with an opening statement delivered by the Head of the Mother, child and school health Department Pamela Zgheib who stated that the Lebanese Ministry of Public Health and the World health Organization recommend mothers to exclusively breastfeed their children for their first six months. Therefore, they should be given water and nutritious supplements and continue breastfeeding up to two years and beyond.

The Chairperson of the International Orthodox Christian Charities Rouba Khoueiry highlighted the importance of raising awareness on breastfeeding and encouraging both private and public sectors to provide mothers with facilities for breastfeeding.
 
ChapuisatTanya Chapuisat, UNICEF Lebanon Representative, said that the latest survey carried out in Lebanon shows that the exclusive breastfeeding rate for the child’s first six months is 14.8% for the Lebanese mothers. This means that a significant number of infants in this country are deprived of the most important elements for their growth and health. According to Chapuisat, extending the scope of breastfeeding can help save 823,000 children below 5 years yearly.
 
Hasbani

“Breastfeeding is not only good for mothers and infants, it is also important in achieving several sustainable development goals; enhancing nutrition, preventing children death, reducing NCD risks and promoting the cognitive development and learning. Breastfeeding helps also reduce poverty and inequality and enhance the economic growth,” Hasbani said.

“Breastfeeding improves as well the national economy, since it reduces the primary healthcare bill and improves the educational attainments, and therefore increases productivity,” he added.

Hasbani announced that the Ministry of Public Health commits itself to improve breastfeeding rate in Lebanon through a national plan to improve and protect breastfeeding.
 
Nadine Hasbani

As a mother for three children and a dietitian, Mrs. Nadine Ghassan Hasbani highlighted the importance of breastfeeding and its positive impact on the child’s growth, in addition to its role in strengthening his immunization system, and protecting him from chronic diseases. As for mothers, breastfeeding helps them burn fat and calories accumulated during pregnancy, and helps the uterus return to its normal size before pregnancy.
Mrs. Hasbani encouraged breastfeeding that enhances the relationship between the mother and the child.
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 25mg Tablet, film coated 1,067,011 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,067,011 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 25mg Tablet, film coated 1,067,011 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,067,011 L.L
C09CA08 OLMETEC B Olmesartan medoxomil - 40mg 40mg Tablet, film coated 920,532 L.L
C09CA08 OLMENOR G Olmesartan medoxomil - 40mg 40mg Tablet, film coated 721,643 L.L
C09DA08 OLMENOR PLUS G Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg Tablet, film coated 628,918 L.L
C09DA08 OLMENOR PLUS G Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 628,918 L.L
C09DB02 OLMENOR COMBI G Olmesartan medoxomil - 20mg, Amlodipine - 5mg Tablet, film coated 679,984 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 20mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,037,446 L.L
C09CA08 OLMETEC B Olmesartan medoxomil - 20mg 20mg Tablet, film coated 888,280 L.L
C09CA08 OLMENOR G Olmesartan medoxomil - 20mg 20mg Tablet, film coated 667,890 L.L
C09CA08 OLMETEC B Olmesartan medoxomil - 10mg 10mg Tablet, film coated 710,893 L.L
C09CA08 OLMENOR G Olmesartan medoxomil - 10mg 10mg Tablet, film coated 526,786 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 7.5mg 7.5mg Tablet 822,432 L.L
N05AH03 OLANZAMED G Olanzapine - 5mg 5mg Tablet 665,522 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 5mg 5mg Tablet 670,577 L.L
N05AH03 OLANZAX 5 G Olanzapine - 5mg 5mg Tablet, mouth dissolving 1,316,966 L.L
N05AH03 OLIZAX 5 G Olanzapine - 5mg 5mg Tablet, mouth dissolving 1,466,580 L.L
N05AH03 OLANZAMED G Olanzapine - 20mg 20mg Tablet 3,941,938 L.L
N05AH03 OLANZAX 10 G Olanzapine - 10mg 10mg Tablet, mouth dissolving 2,329,327 L.L
N05AH03 OLIZAX 10 G Olanzapine - 10mg 10mg Tablet, mouth dissolving 2,598,096 L.L
N05AH03 OLANZAMED G Olanzapine - 10mg 10mg Tablet 902,294 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 10mg 10mg Tablet 822,432 L.L
S01AE01 OFLOX B Ofloxacin - 3mg/ml 0.3% Drops solution 366,869 L.L
S01AE01 OPTIFLOX G Ofloxacin - 3mg/ml 3mg/ml Drops suspension 143,791 L.L
S02AA16 OFLOMED G Ofloxacin - 3mg/ml 3mg/ml Drops solution 317,403 L.L
J01MA01 OFLACIN G Ofloxacin - 200mg 200mg Tablet, film-scored 602,041 L.L
J01MA01 OFLOMED G Ofloxacin - 200mg 200mg Tablet, film-scored 601,530 L.L
S01AE01 OFLOX B Ofloxacin - 0.3% 0.3% Drops solution 366,869 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025